HDAC9 and cancer: In thisstudy, we evaluated the anti-proliferative effects of a histone deacetylase (HDAC)inhibitor, entinostat, which was computationally predicted to show anti-cancer activity,as confirmed in in vitro and in vivo models of GEP-NETs.